Organization of Medical Care and Drug Supply for Patients with Osteogenesis Imperfecta in the Republic of Bashkortostan

Abstract

Osteogenesis imperfecta is a group of rare hereditary diseases of connective tissue, which are based on a defective collagen formation. The main focus of the osteogenesis imperfecta drug therapy is a cyclical use of bisphosphonates (pamidronic acid). The article presents the procedure of health care and drug supply organization for children with that disease, including the development of the regulatory framework.

Keywords

• osteogenesis imperfecta
• children
• medical care
• drug supply.